GlassScriptPhysician profile
Norman C Denton
NPI 1881612059
$292.16
in general payments reported to CMS, 2019-2025
12 companies · $29.75 in 2025
The $29.75 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $49.22 · 2020: $64.25 · 2021: $27.31 · 2022: $57.85 · 2023: $14.95 · 2024: $48.83 · 2025: $29.75.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $93.53.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $93.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Theratechnologies INC. | $107.29 | 2019-2022 | |
| Sanofi Pasteur INC. | $35.57 | 2022-2024 | |
| Merck Sharp & Dohme LLC | $28.77 | 2022-2025 | Gardasil 9, Capvaxive |
| Cequr Corporation | $15.00 | 2025 | Cequr Simplicity |
| Qiagen, LLC | $14.95 | 2023 | |
| Edwards Lifesciences Corporation | $14.42 | 2024 | Sapien 3 Ultra Resilia |
| Abbvie INC. | $13.85 | 2020 | |
| Abbott Laboratories | $13.30 | 2021 | |
| Xeris Pharmaceuticals, INC. | $13.10 | 2024 | Gvoke Hypopen |
| Lilly USA, LLC | $12.66 | 2020 | |
| Medtronic, INC. | $11.93 | 2022 | |
| Novo Nordisk INC | $11.32 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Norman Denton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.